Taiho Oncology: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies9 active (5 recruiting now)
Total Tracked Studies (2018 to 2026)16 (14 with California sites)
Completed vs Early-Stopped Studies3 completed / 4 stopped (25.0% stop rate)
Median Closed Enrollment108 participants
FDA Drugs@FDA Original Approvals3 all-time (2 from 2018 to 2026)
Physical Hospital Site Disclosure97.4% named hospital slots

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk